Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Transplantation Proceedings

• Publication date

  1996-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 8769214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Weaning Of Immunosuppression In Long‐Term Liver Transplant Recipients

  1995cited by this paper
• Corticosteroid withdrawal after liver transplantation.

  1995cited by this paper
• Monotherapy with cyclosporine for chronic immunosuppression in pediatric liver transplant recipients.

  1994cited by this paper
• Steroid withdrawal from long-term immunosuppression in liver allograft recipients.

  1993cited by this paper
• AN ANALYSIS OF CYCLOSPORINE EFFICACY AND TOXICITY AFTER LIVER TRANSPLANTATION

  1988cited by this paper

• Chapter 37 – Nutritional Aspects of Transplantation in Adults

  2015cites this paper
• A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 years.

  2013cites this paper
• Single-Agent Immunosuppression After Liver Transplantation

  2012cites this paper
• Minimization of steroids in liver transplantation

  2009cites this paper
• Daclizumab induction and maintenance steroid‐free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts

  2006cites this paper
• Minimization of immunosuppression with thymoglobuline pre‐treatment and HCV recurrence in liver transplantation

  2005cites this paper
• Preliminary Results of a “Prope” Tolerogenic Regimen with Thymoglobulin Pretreatment and Hepatitis C Virus Recurrence in Liver Transplantation

  2005cites this paper
• 33 – Nutritional Aspects of Adult Liver Transplantation

  2005cites this paper
• Promising early results with immunosuppression using rabbit anti‐thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients

  2004cites this paper
• Avoiding steroids in solid organ transplantation

  2003cites this paper
• Immunosuppression with rapid steriod reduction among predominantly HBV liver transplantation recipients: initial experience.

  2003cites this paper
• Single-agent immunosuppression after liver transplantation: what is possible?

  2002cites this paper
• Steroid withdrawal in long-term liver transplant recipients.

  2001cites this paper
• Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil.

  2001cites this paper
• Steroid Withdrawal in Liver Transplant Recipients

  2001cites this paper
• Adult liver transplantation and steroidazathioprine withdrawal in cyclosporine (Sandimmun)‐based immunosuppression 5 year results of a prospective study

  2001cites this paper
• Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression – 5 year results of a prospective study

  2001cites this paper
• Steroid withdrawal in liver transplant recipients.

  2001cites this paper
• STEROID WITHDRAWAL IN LIVER TRANSPLANTATION

  2000cites this paper
• Steroid withdrawal in liver transplantation: benefits, risks, and unanswered questions.

  2000cites this paper
• Early steroid withdrawal in liver transplantation is safe and beneficial.

  1999cites this paper
• Cyclosporine monotherapy in long-term pediatric liver transplant recipients.

  1998cites this paper
• Lipid abnormalities in stable liver transplant recipients – effects of cyclosporin, tacrolimus, and steroids

  1998cites this paper
• Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients.

  1998cites this paper
• Withdrawal of immunosuppression in liver allograft recipients.

  1998cites this paper
• cyclosporin, tacrolimus, and steroids

  1997cites this paper